Semi-annual Earnings Preannouncement for 2025
Filed with SSE · · 2 pages · Chinese
Lionco Pharmaceutical Group Co., Ltd. on 6ix
Earlier from Lionco Pharmaceutical
- Indicative Announcement on Expected Satisfaction of Conversion Price Correction Conditions for "Lionco Convertible Bonds"
- Announcement on Convening the 2024 Annual and Q1 2025 Performance Briefing
- Announcement on Follow-up Rating Results of "Lionco Convertible Bonds" in 2025
- Announcement on Early Return of Raised Funds for Temporary Supplement to Current Capital
- Announcement on Resolution of the 2024 Annual General Meeting
Later from Lionco Pharmaceutical
- Announcement on No Downward Revision of Conversion Price of "Lionco Convertible Bonds" and Suspension and Resumption of Conversion
- Announcement on Resolutions of the 20th Meeting of the 4th Board of Supervisors
- Announcement on Convening the 2025 Semi-annual Performance Briefing
- Announcement on Resolutions of the 21st Meeting of the 4th Board of Supervisors
- Announcement on Resolutions of the 1st Meeting of the 5th Board of Directors
Follow Lionco Pharmaceutical into a list and get an email when it puts out news.
Follow Lionco Pharmaceutical